Functional homologs of cyanovirin-N amenable to mass production in prokaryotic and eukaryotic hosts

Protein Expression and Purification

Volumn 26, Issue 1, 2002, Pages 42-49

  Mori, Toshiyuki ^a   Barrientos, Laura G ^b   Han, Zhaozhong ^a   Gronenborn, Angela M ^b   Turpin, Jim A ^c   Boyd, Michael R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

Anti HIV; CV N; Cyanovirin N; Cyanovirins; HIV; Microbicides

Indexed keywords

BACTERIA (MICROORGANISMS); EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS; PROKARYOTA;

AMIDASE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BACTERIAL PROTEIN; CARRIER PROTEIN; CYANOVIRIN N; GLYCOPEPTIDASE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECT; EUKARYOTIC CELL; GENETIC TRANSFORMATION; GENETICS; GLYCOSYLATION; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; PICHIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROKARYOTIC CELL; PROTEIN DENATURATION; TEMPERATURE; THERMODYNAMICS;

AMIDOHYDROLASES; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTI-HIV AGENTS; BACTERIAL PROTEINS; CARRIER PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EUKARYOTIC CELLS; GLYCOSYLATION; HIV-1; MOLECULAR SEQUENCE DATA; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE; PICHIA; PROKARYOTIC CELLS; PROTEIN DENATURATION; TEMPERATURE; THERMODYNAMICS; TRANSFORMATION, GENETIC;

EID: 0036417851     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1046-5928(02)00513-2     Document Type: Article

References (37)

1. M.R. Boyd, K.R. Gustafson, J.B. McMahon, R.H. Shoemaker, B.R. O'Keefe, T. Mori, R.J. Gulakowski, L. Wu, M. Rivera, C.M. Laurencot, J.H. Cardellina II, R.W. Buckheit Jr., P.L. Nara, L.K. Pannell, R.C. Sowder II, L.E. Henderson, Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development, Antimicrob. Agents Chemother. 41 (7) (1997) 1521-1530.
2. K.R. Gustafson, R.C. Sowder II, L.E. Henderson, J.H. Cardellina II, J.B. McMahon, U. Rajamani, L.K. Pannell, M.R. Boyd, Isolation, primary sequence determination, and disulfide bond structure of cyanovirin-N, an anti-HIV (human immunodeficiency virus) protein from the cyanobacterium Nostoc ellipsosporum, Biochem. Biophys. Res. Commun. 238 (1) (1997) 223-228.
3. T. Mori, K.R. Gustafson, L.K. Pannell, R.H. Shoemaker, L. Wu, J.B. McMahon, M.R. Boyd, Recombinant production of cyano-virin-N, a potent human immunodeficiency virus-inactivating protein derived from a cultured cyanobacterium, Protein Expr. Purif. 12 (2) (1998) 151-158.
4. C.A. Bewley, K.R. Gustafson, M.R. Boyd, D.G. Covell, A. Bax, G.M. Clore, A.M. Gronenborn, Solution structure of cyanovirin-N, a potent HIV-inactivating protein, Nat. Struct. Biol. 5 (7) (1998) 571-578.
5. F. Yang, C.A. Bewley, J.M. Louis, K.R. Gustafson, A.M. Gronenborn, G.M. Clore, A. Wlodower, Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping, J. Mol. Biol. 288 (3) (1999) 403-412.
6. B. Dey, D.L. Lerner, P. Lusso, M.R. Boyd, J.H. Elder, E.A. Berger, Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses, J. Virol. 74 (10) (2000) 4562-4569.
7. T. Mori, R.H. Shoemaker, R.J. Gulakowski, B.L. Krepps, J.B. McMahon, K.R. Gustafson, L.K. Pannell, M.R. Boyd, Analysis of sequence requirements for biological activity of cyanovirin-N, a potent HIV (human immunodeficiency virus)-inactivating protein, Biochem. Biophys. Res. Commun. 238 (1) (1997) 218-222.
8. M.T. Esser, T. Mori, I. Mondor, Q. Sattentau, B. Dey, E.A. Berger, M.R. Boyd, J.D. Lifson, Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not aNect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120, J. Virol. 73 (5) (1999) 4360-4371.
9. T. Mori, M.R. Boyd, Cyanovirin-N, a potent human immunode-ficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits soluble CD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells, Antimicrob. Agents Chemother. 45 (3) (2001) 664-672.
10. P.D. Kwong, R. Wyatt, J. Robinson, R.W. Sweets, J. Sodroski, W.A. Hendrickson, Structure of an HIV gp120 envelope glyco-protein in complex with the CD4 receptor and a neutralizing human antibody, Nature 393 (6686) (1998) 648-659.
11. A.M. Trkola, M. Purtscher, T. Muster, C. Ballaun, A. Buchacher, N. Sullivan, K. Srinivasan, J. Sodroski, J.P. Moore, H. Katinger, Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1, J. Virol. 70 (12) (1996) 1100-1108.
12. R. Wyatt, P.D. Kwong, E. Desjardins, R.W. Sweet, J. Robinson, W.A. Hendrickson, J.G. Sodroski, The antigenic structure of the HIVgp120 envelopeglycoprotein, Nature 393 (6686) (1998) 705-711.
13. J. Stephenson, Microbicides: Ideas flourish, money to follow?, JAMA 283 (14) (2000) 1811-1812.
14. L. Van Damme, Z.F. Rosenberg, Microbicides and barrier methods in HIV prevention, AIDS 13 (Suppl. A) (1999) S85-S92.
15. M.P. D'Souza, J.S. Cairns, S.F. Plaeger, Current evidence and future directions for targeting HIV entry: Therapeutic and prophylactic strategies, JAMA 284 (2) (2000) 215-222.
16. R. Fischer, N. Emans, Molecular farming of pharmaceutical proteins, Transgenic Res. 9 (4-5) (2000) 279-299.
17. R. Fischer, K. Hoffmann, S. Schillberg, N. Emans, Antibody production by molecular farming in plants, J. Biol. Regul. Homeost. Agents 14 (2) (2000) 83-92.
18. C. De Wilde, H. Van Houdt, S. De Buck, G. Angenon, G. De Jaeger, A. Depicker, Plants as bioreactors for protein production: Avoiding the problem of transgene silencing, Plant Mol. Biol. 43 (2-3) (2000) 347-359.
19. L.M. Houdebine, Transgenic animal bioreactors, Transgenic Res. 9 (4-5) (2000) 305-320.
20. M.F. Brink, M.D. Bishop, F.R. Pieper, Developing effcient strategies for the generation of transgenic cattle which produce biopharmaceuticals in milk, Theriogenology 53 (1) (2000) 139-148.
21. D.P. Pollock, J.P. Kutzko, E. Birck-Wilson, J.L. Williams, Y. Echelard, H.M. Meade, Transgenic milk as a method for the production of recombinant antibodies, J. Immunol. Methods 231 (1/2) (1999) 147-157.
22. D.C. Goodwin, S.B. Lee, Microwave miniprep of total genomic DNA from fungi, plants, protists and animals for PCR, Biotechniques 15 (3) (1993) 438-444.
23. L.G. Barrientos, J.M. Louis, I. Botos, T. Mori, Z.Z. Han, B.R. O'Keefe, M.R. Boyd, A. Wlodawer, A.M. Gronenborn, The domain-swapped dimer of cyanovirin-N is in a metastable folding intermediate. Reconciliation of X-ray and NMR structures, Structure 10 (5) (2002) 673-686.
24. C.N. Pace, B.A. Shirley, J.A. Thomson, Measuring the conformational stability of a protein, in: T.E. Creighton (Ed.), Protein Structure: A Practical Approach, IRL Press, Oxford, NY, 1989, pp. 311-329.
25. R.W. Buckheit Jr., J.L. Roberson, C. Lackman-Smith, J.R. Wyatt, T.A. Vickers, D.J. Ecker, Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320), AIDS Res. Hum. Retrovir. 10 (11) (1994) 1497-1506.
26. R.W. Buckheit Jr., V. Fliakas-Boltz, W.D. Decker, J.L. Roberson, C.A. Pyle, E.L. White, B.J. Bowden, J.B. McMahon, M.R. Boyd, J.P. Bader, D.G. Nickell, H. Barth, T.K. Antonucci, Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors, Antiviral Res. 25 (1) (1994) 43-56.
27. R.W. Buckheit Jr., M.G. Hollingshead, E.L. White, J. Germany-Decker, E.L. White, J.B. McMahon, L.B. Allen, L. Ross, W.D. Decker, L. Westbrook, W.M. Shannon, Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor, Antiviral Res. 21 (3) (1993) 247-265.
28. R.J. Gulakowski, J.B. McMahon, P.G. Staley, R.A. Moran, M.R. Boyd, A semiautomated multiparameter approach for anti-HIV drug screening, J. Virol. Methods 33 (1991) 87-100.
29. F. Maley, R.B. Trimble, A.L. Tarentino, T.H Plummer Jr., Characterization of glycoproteins and their associated oligosac-charides through the use of endoglycosidases, Anal. Biochem. 180 (2) (1989) 195-204.
30. M.W. MacArthur, J.M. Thornton, Influence of proline residues on protein conformation, J. Mol. Biol. 218 (2) (1991) 397-412.
31. M.W. Matthews, H. Nicholson, W.J. Becktel, Enhanced protein thermostability from site-directed mutations that decrease the entropy of unfolding, Proc. Natl. Acad. Sci. USA 84 (19) (1987) 6663-6667.
32. U. Conrad, U. Fiedler, Compartment-specific accumulation of recombinant immunoglobulins in plant cells: An essential tool for antibody production and immunomodulation of physiological functions and pathogen activity, Plant Mol. Biol. 38 (1/2) (1998) 101-109.
33. J.M.. Staub, B. Garcia, J. Graves, P.T.J. Hajdukiewicz, P. Hunter, N. Nehra, V. Paradkar, M. Schlittler, J.A. Carroll, L. Spatola, D. Ward, G. Ye, D.A. Russell, High-yield production of a human therapeutic protein in tobacco chloroplasts, Nat. Biotechnol . 18 (3) (2000) 333-338.
34. A.A. McCormick, M.H. Kumagai, K. Hanley, T.H. Turpen, I. Hakim, L.K. Grill, D. Tuse, S. Levy, R. Levy, Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants, Proc. Natl. Acad. Sci. USA 96 (2) (1999) 703-708.
35. L. Zeitlin, S.S. Olmsted, T.R. Moench, M.S. Co, B.J. Martinell, V.M. Paradkar, D.R. Russell, C. Queen, R.A. Cone, K.J. Whaley, A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes, Nat. Biotechnol. 16 (13) (1998) 1361-1364.
36. C.O. Tacket, H.S. Mason, A review of oral vaccination with transgenic vegetables, Microbes Infect. 1 (10) (1999) 777-783.
37. C.O. Tacket, H.S. Mason, G. Losonsky, J.D. Clements, M.M. Levine, C.J. Arntzen, Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato, Nat. Med. 4 (5) (1998) 607-609.